Published in Chest on February 01, 2009
Concurrent sarcoidosis and lung cancer. Chest (2009) 0.90
Lung Cancer Associated with Sarcoidosis - A case report -. Korean J Thorac Cardiovasc Surg (2011) 0.80
Sarcoidosis or sarcoid reaction? Chest (2009) 0.75
Sarcoid-like reaction in Cryptococcus neoformans infection. BMJ Case Rep (2012) 0.75
A case of pulmonary sarcoidosis preceding polycythemia vera with literature review. Rheumatol Int (2010) 0.75
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Lancet (2010) 10.79
Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer. J Clin Oncol (2010) 4.64
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial. Lancet Oncol (2013) 3.38
Comparison of airway pressure release ventilation to conventional mechanical ventilation in the early management of smoke inhalation injury in swine. Crit Care Med (2011) 2.77
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. Clin Cancer Res (2007) 2.50
Prostate cancer clinical trial end points: "RECIST"ing a step backwards. Clin Cancer Res (2005) 2.44
Respiratory dialysis: reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal. Crit Care Med (2011) 2.42
A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index. Eur Urol (2012) 2.27
Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer. J Clin Oncol (2012) 2.26
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology (2013) 2.24
Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials. Nat Clin Pract Oncol (2006) 1.99
Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res (2009) 1.99
Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer. J Clin Oncol (2014) 1.95
End points and outcomes in castration-resistant prostate cancer: from clinical trials to clinical practice. J Clin Oncol (2011) 1.94
Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer. Ann Intern Med (2010) 1.84
Platelet-derived growth factor receptor inhibition and chemotherapy for castration-resistant prostate cancer with bone metastases. Clin Cancer Res (2007) 1.74
Two-stage treatment of hip periprosthetic joint infection is associated with a high rate of infection control but high mortality. Clin Orthop Relat Res (2013) 1.74
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer. J Clin Oncol (2008) 1.71
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res (2010) 1.68
Androgen deprivation and thromboembolic events in men with prostate cancer. Cancer (2011) 1.62
Community meetings for emergency research community consultation. Crit Care Med (2008) 1.58
Novel tracers and their development for the imaging of metastatic prostate cancer. J Nucl Med (2008) 1.56
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer. Clin Cancer Res (2010) 1.40
Transitioning the respiratory therapy workforce for 2015 and beyond. Respir Care (2011) 1.40
In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS One (2012) 1.40
When progressive disease does not mean treatment failure: reconsidering the criteria for progression. J Natl Cancer Inst (2012) 1.28
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET. J Nucl Med (2010) 1.27
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer. J Clin Oncol (2013) 1.21
Phase I pharmacokinetic and biodistribution study with escalating doses of ²²³Ra-dichloride in men with castration-resistant metastatic prostate cancer. Eur J Nucl Med Mol Imaging (2013) 1.20
Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT. J Nucl Med (2011) 1.18
Validation and clinical utility of prostate cancer biomarkers. Nat Rev Clin Oncol (2013) 1.17
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapy. J Nucl Med (2008) 1.15
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy. J Clin Oncol (2007) 1.14
Computer-aided quantitative bone scan assessment of prostate cancer treatment response. Nucl Med Commun (2012) 1.13
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer. Eur J Nucl Med Mol Imaging (2014) 1.10
Developing imaging strategies for castration resistant prostate cancer. Acta Oncol (2011) 1.10
Bis[(2-pyridyl)(2-pyridylamino)methanolato]cobalt(III) perchlorate: a consequence of cobalt ion-assisted oxidative deamination of a tris(pyridyl)aminal ligand. Acta Crystallogr C (2005) 1.09
Does a simple bedside sonographic measurement of the inferior vena cava correlate to central venous pressure? J Emerg Med (2011) 1.09
Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease. Mov Disord (2005) 1.08
Partial two-stage exchange for infected total hip arthroplasty: a preliminary report. Clin Orthop Relat Res (2014) 1.06
Leukocyte esterase reagent strips for the rapid diagnosis of periprosthetic joint infection. J Arthroplasty (2012) 1.04
Inspiratory flow-volume curve evaluation for detecting upper airway disease. Respir Care (2009) 1.02
Large-diameter metal-on-metal total hip arthroplasty: dislocation infrequent but survivorship poor. Clin Orthop Relat Res (2014) 0.98
Vocal cord dysfunction, paradoxic vocal fold motion, or laryngomalacia? Our understanding requires an interdisciplinary approach. Otolaryngol Clin North Am (2010) 0.97
Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial. Cancer Chemother Pharmacol (2011) 0.96
The neural substrates of enhanced salt appetite after repeated sodium depletions. Brain Res (2007) 0.95
Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer. Clin Cancer Res (2010) 0.95
Imaging therapeutic response in human bone marrow using rapid whole-body MRI. Magn Reson Med (2004) 0.93
Cardiopulmonary exercise test interpretation using age-matched controls to evaluate exertional dyspnea. Mil Med (2009) 0.93
(11)C-acetate PET imaging in prostate cancer. Eur J Nucl Med Mol Imaging (2007) 0.93
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer. BJU Int (2011) 0.90
Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer. Curr Treat Options Oncol (2012) 0.89
A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors. Cancer Chemother Pharmacol (2011) 0.89
Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer. PLoS One (2010) 0.88
Assessing outcomes in prostate cancer clinical trials: a twenty-first century tower of Babel. Cancer (2008) 0.88
Inflammatory mediators in smoke inhalation injury. Inflamm Allergy Drug Targets (2009) 0.88
Perioperative complications of simultaneous versus staged unicompartmental knee arthroplasty. Clin Orthop Relat Res (2011) 0.87
Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis. J Neuroimaging (2012) 0.86
Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers. Xenobiotica (2013) 0.86
Development of a deployment course for graduating military internal medicine residents. Mil Med (2006) 0.85
Medial mobile bearing unicompartmental knee arthroplasty: early survivorship and analysis of failures in 1000 consecutive cases. J Arthroplasty (2013) 0.84
Unicompartmental knee arthroplasty: incidence of transfusion and symptomatic thromboembolic disease. Orthopedics (2010) 0.84
Achieving stability and lower-limb length in total hip arthroplasty. J Bone Joint Surg Am (2010) 0.83
Protein and microRNA biomarkers from lavage, urine, and serum in military personnel evaluated for dyspnea. BMC Med Genomics (2014) 0.80
Targeting bone physiology for the treatment of metastatic prostate cancer. Clin Adv Hematol Oncol (2013) 0.80
Airway humidification during high-frequency percussive ventilation. Respir Care (2009) 0.80
Expression of prostate-specific membrane antigen in renal cortical tumors. Mod Pathol (2008) 0.80
Opioid mechanisms that mediate the palatability of and appetite for salt in sodium replete and deficient states. Physiol Behav (2012) 0.80
Coordination versatility of tridentate pyridyl aroylhydrazones towards iron: tracking down the elusive aroylhydrazono-based ferric spin-crossover molecular materials. Dalton Trans (2012) 0.79
Langerhans cell histiocytosis presenting as uncontrolled asthma. Case Rep Med (2013) 0.79
Vocal cord dysfunction induced by methacholine challenge testing. Chest (2002) 0.79
Variant superficial fibular (peroneal) nerve anatomy in the middle third of the lateral leg. Clin Anat (2007) 0.79
Relapsing polychondritis in the Department of Defense population and review of the literature. Semin Arthritis Rheum (2012) 0.79
Diagnosis and management of chronic lung disease in deployed military personnel. Ther Adv Respir Dis (2013) 0.78
Comparison of Predicted Exercise Capacity Equations and the Effect of Actual versus Ideal Body Weight among Subjects Undergoing Cardiopulmonary Exercise Testing. Cardiol Res Pract (2013) 0.78
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measure. J Oncol Pract (2013) 0.78
Inducible laryngeal obstruction during exercise: moving beyond vocal cords with new insights. Phys Sportsmed (2015) 0.78
Constrictive bronchiolitis in soldiers. N Engl J Med (2011) 0.77
Unprecedented [V2O]6+ core of a centrosymmetric thiosemicarbazonato dimer: spontaneous deoxygenation of oxovanadium(IV). Inorg Chem (2006) 0.77
Do sex and BMI predict or does stem design prevent muscle damage in anterior supine minimally invasive THA? Clin Orthop Relat Res (2015) 0.77
Behavioral cross-sensitization between morphine-induced locomotion and sodium depletion-induced salt appetite. Pharmacol Biochem Behav (2009) 0.77
Primary and revision anterior supine total hip arthroplasty: an analysis of complications and reoperations. Instr Course Lect (2013) 0.77
Abnormal preoperative MRI does not correlate with failure of UKA. J Arthroplasty (2013) 0.77
Castration resistant, taxane naïve metastatic prostate cancer: current clinical approaches and future directions. J Urol (2007) 0.77
Does preoperative patellofemoral joint state affect medial unicompartmental arthroplasty survival? Orthopedics (2011) 0.77
Progressive vocal cord dysfunction subsequent to a chlorine gas exposure. J Voice (2005) 0.77
Outpatient Arthroplasty is Here Now. Instr Course Lect (2016) 0.77
Isolated right ventricular failure in scleroderma heart disease. Cardiol Rev (2004) 0.76
Difficult-to-treat asthma or vocal cord dysfunction? Am J Respir Crit Care Med (2012) 0.76
Heterometallic dithiolene complexes formed by stepwise displacement of cyclopentadienyl ligands from nickelocene with CpMo(S2C2Ph2)2. Inorg Chem (2006) 0.76
Response. Radiology (2015) 0.75
A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen. Clin Genitourin Cancer (2012) 0.75
Wound management. J Orthop Res (2014) 0.75
Repetitively dosed docetaxel and ¹⁵³samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer. Cancer (2013) 0.75
Achieving stability and lower limb length in total hip arthroplasty. Instr Course Lect (2011) 0.75
Medial Unicompartmental Knee Arthroplasty. Instr Course Lect (2017) 0.75